Sg Americas Securities, LLC Stoke Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 14,917 shares of STOK stock, worth $164,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,917

Previous 68,601 78.26%

Holding current value

$164,385

Previous $927,000 80.26%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$12.24 - $15.92 $657,092 - $854,649	-53,684 Reduced 78.26%	14,917 $183,000
Q2 2024 Jul 12, 2024	BUY	$11.03 - $17.52 $650,141 - $1.03 Million	58,943 Added 610.3%	68,601 $927,000
Q1 2024 May 06, 2024	SELL	$4.12 - $14.17 $22,425 - $77,127	-5,443 Reduced 36.04%	9,658 $130,000
Q4 2023 Jan 12, 2024	BUY	$3.37 - $5.4 $5,203 - $8,337	1,544 Added 11.39%	15,101 $79,000
Q3 2023 Oct 13, 2023	BUY	$3.78 - $11.99 $51,245 - $162,548	13,557 New	13,557 $53,000
Q3 2022 Oct 31, 2022	BUY	$12.56 - $22.53 $99,638 - $178,730	7,933 New	7,933 $102,000
Q2 2022 Jul 29, 2022	SELL	$10.36 - $23.93 $1.89 Million - $4.37 Million	-182,591 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$17.19 - $26.1 $2.62 Million - $3.97 Million	152,149 Added 499.8%	182,591 $3.84 Million
Q4 2021 Feb 07, 2022	SELL	$18.11 - $30.72 $205,946 - $349,347	-11,372 Reduced 27.2%	30,442 $730,000
Q3 2021 Nov 01, 2021	BUY	$23.65 - $34.44 $584,084 - $850,564	24,697 Added 144.28%	41,814 $1.06 Million
Q2 2021 Aug 12, 2021	BUY	$30.53 - $41.09 $80,873 - $108,847	2,649 Added 18.31%	17,117 $576,000
Q1 2021 May 13, 2021	BUY	$36.08 - $69.81 $522,005 - $1.01 Million	14,468 New	14,468 $562,000
Q4 2020 Feb 04, 2021	SELL	$33.62 - $61.93 $858,184 - $1.58 Million	-25,526 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$22.23 - $37.48 $5,468 - $9,220	246 Added 0.97%	25,526 $855,000
Q2 2020 Jul 20, 2020	BUY	$20.26 - $29.73 $374,749 - $549,915	18,497 Added 272.7%	25,280 $602,000
Q1 2020 Apr 30, 2020	BUY	$16.8 - $34.15 $45,208 - $91,897	2,691 Added 65.76%	6,783 $155,000
Q4 2019 Jan 28, 2020	BUY	$20.01 - $30.79 $81,880 - $125,992	4,092 New	4,092 $116,000
Q3 2019 Nov 04, 2019	SELL	$20.53 - $37.72 $275,102 - $505,448	-13,400 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$25.53 - $29.17 $342,102 - $390,878	13,400 New	13,400 $391,000

Others Institutions Holding STOK

# of Institutions

125

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $434M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Stoke Therapeutics, Inc. Transaction History